A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

NCT06340490 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: RJMty19 (CD19-CAR-DNT cells)

Sponsor

Guangdong Ruishun Biotech Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]